Search Within

Infectious Disease

  1. "Boglarka Gyurkocza"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (8)
  3. Research Letter (1)
Groups
  1. Bone Marrow Transplant (18)
  2. Center for Hematologic Malignancies (18)
  3. Department of Medicine (18)
  4. Division of Subspecialty Medicine (18)
  5. Hematologic Malignancies, Division of (18)
  6. Survivorship Research (18)

More Groups

People
  1. Boglarka Gyurkocza (18)
  2. Miguel-Angel Perales (15)
  3. Sergio Giralt (14)
  4. Doris Ponce (13)
  5. Marcel Van Den Brink (13)
  6. Jonathan Peled (12)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (1)
  5. 2020 (2)
  6. 2019 (3)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (6)
  2. Blood (3)
  3. Transplantation and Cellular Therapy (3)
  4. Science Translational Medicine (2)
  5. Cancer Cell (1)
  6. Cell (1)

More Publications

Publishers
  1. Elsevier Inc. (9)
  2. American Society of Hematology (3)
  3. American Association for the Advancement of Science (2)
  4. Cell Press (2)
  5. American Society of Clinical Oncology (1)
  6. Massachusetts Medical Society (1)

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Letermovir for prevention of recurrent cytomegalovirus in high-risk allogeneic hematopoietic cell transplantation recipients
    Journal Article

    Han, G.; Stern, A.; Lee, Y. J.; Li, Y.; Dahi, P. B.; Tamari, R.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; Shaffer, B.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients
    Journal Article

    Nguyen, C. L.; Markey, K. A.; Miltiadous, O.; Dai, A.; Waters, N.; Sadeghi, K.; Fei, T.; Shouval, R.; Taylor, B. P.; Liao, C.; more...
    Cell (2023)

    Fulltext@MSK | Save
  • Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
    Research Letter

    Stuver, R.; Shah, G. L.; Korde, N. S.; Roeker, L. E.; Mato, A. R.; Batlevi, C. L.; Chung, D. J.; Doddi, S.; Falchi, L.; Gyurkocza, B.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Hematopoietic cell transplantation is feasible in patients with prior COVID-19 infection
    Journal Article

    Shah, N.; Dahi, P. B.; Ponce, D. M.; Sauter, C. S.; Shaffer, B. C.; Chung, D. J.; Politikos, I.; Lin, R. J.; Giralt, S. A.; Papanicolaou, G.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Cellular therapy during COVID-19: Lessons learned and preparing for subsequent waves
    Journal Article

    Nawas, M. T.; Shah, G. L.; Feldman, D. R.; Ruiz, J. D.; Robilotti, E. V.; Aslam, A. A.; Dundas, M.; Kamboj, M.; Barker, J. N.; Cho, C.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • A single-center, open-label trial of isavuconazole prophylaxis against invasive fungal infection in patients undergoing allogeneic hematopoietic cell transplantation
    Journal Article

    Stern, A.; Su, Y.; Lee, Y. J.; Seo, S.; Shaffer, B.; Tamari, R.; Gyurkocza, B.; Barker, J.; Bogler, Y.; Giralt, S.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation
    Journal Article

    Peled, J. U.; Gomes, A. L. C.; Devlin, S. M.; Littmann, E. R.; Taur, Y.; Sung, A. D.; Weber, D.; Hashimoto, D.; Slingerland, A. E.; Slingerland, J. B.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Pre-transplant fecal microbial diversity independently predicts critical illness after hematopoietic cell transplantation
    Meeting Abstract

    Adhi, F. I.; Littmann, E. R.; Taur, Y.; Maloy, M. A.; Markey, K. A.; Fontana, E.; Amoretti, L. A.; Wright, R.; Sanchez-Escamilla, M.; Castillo Flores, N.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Multicenter microbiota analysis indicates that pre-HCT microbiota injury is prevalent across geography and predicts poor overall survival
    Meeting Abstract

    Peled, J. U.; Gomes, A.; Stein-Thoeringer, C.; Slingerland, J.; Slingerland, A. E.; Weber, D.; Markey, K. A.; Smith, M.; Ponce, D. M.; Clurman, A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Microbiota injury in auto-HCT is frequent, occurs across geography, and is comparable to that observed in allo-HCT
    Meeting Abstract

    Khan, N.; Peled, J. U.; Gomes, A.; Devlin, S. M.; Rondon Clavo, C.; Clurman, A.; Slingerland, J.; Slingerland, A. E.; Maloy, M. A.; Sung, A. D.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save